BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Drug Development

  Ora Release: Ora-CAC Model Delivers Successful Phase III Data For Ocular Therapeutix’s DEXTENZA (OTX-DP) For Treatment Of Allergic Conjunctivitis

  November 12, 2015

   · 

  3 min read
• Drug Development

  Allergan Presents Data At The 2015 American Academy of Ophthalmology Annual Meeting In Las Vegas

  November 12, 2015

   · 

  3 min read
• Drug Development

  Blueprint Medicines To Present Preclinical Data At 2015 American Society of Hematology Annual Meeting Demonstrating Anti-Tumor Activity Of BLU-285 In A Model Of Acute Myeloid Leukemia

  November 12, 2015

   · 

  6 min read
• Business

  McKesson Corporation Announces New Distribution Center In Hamptonburgh, New York

  November 12, 2015

   · 

  2 min read
• BioMidwest

  Genomenext’s Genomic Analysis Pipeline Effectively Delivers Clinically Actionable Genetic Data Driving Nationwide Children’s Hospital’s Efforts To Win The CLARITY Undiagnosed Challenge

  November 12, 2015

   · 

  6 min read
• Genetown

  HeartWare Presentation At The Canaccord Genuity 2015 Medical Technology & Diagnostics Forum To Be Webcast

  November 12, 2015

   · 

  1 min read
• Biotech Beach

  ASRT Foundation And Toshiba America Medical Systems Announce Winners Of The Inaugural Safety First Grants

  November 12, 2015

   · 

  4 min read
• Business

  Pressure BioSciences, Inc. Reports Record Third Quarter And Year-To-Date 2015 Financial Results And Provides Business Update

  November 12, 2015

   · 

  4 min read
• Portola To Host Analyst And Investor Day On November 19

  November 12, 2015

   · 

  1 min read
• Drug Development

  Derma Sciences To Hold Conference Call On November 12 To Discuss Data Monitoring Committee Pre-Specified Interim Analysis Of The Aclerastide Phase 3 Trials

  November 12, 2015

   · 

  1 min read